Grace Therapeutics Inc. (GRCE)
Market Open
11 Sep, 13:54
NASDAQ (CM) NASDAQ (CM) Primary $
2. 25
-0
-0.2212%
$
34.5M Market Cap
- P/E Ratio
- Div Yield
17,088 Volume
0 Eps
$ 2.26
Previous Close 
Want to track GRCE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Grace Therapeutics Inc. (GRCE) Statistics
Valuation metrics
Market Cap 34.5M
Enterprise value 20.42M
Trailing P/E (ttm) -1.67
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) -
Price/Book (mrq) 0.75
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.8
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 186.3K
Average volume (90 days) 146.33K
Price summary
52-Week low 1.79
52-Week high 5.18
Beta -
50-Day moving average 2.19
200-Day moving average 3.45
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:6
Last split Date 10 Jul 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.43%
Return on equity -0.36%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.24
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.8
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 11.47%
Book value per share (mrq) 2.79
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
